首页>
外国专利>
Methods of treating sickle cell anemia-related conditions with MK-801 or memantine
Methods of treating sickle cell anemia-related conditions with MK-801 or memantine
展开▼
机译:用MK-801或美金刚治疗镰状细胞性贫血相关疾病的方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
Sickle cell anemia is a genetic disease characterized by red blood cells that assume an abnormal, rigid, sickle shape. Acute complications of Sickle cell anemia are treated symptomatically with analgesics and transfusions, and a prophylactic treatment of sickle cell crisis is long term application of hydroxyurea. According to the present invention, an N-methyl D-aspartate receptor (NMDAR) blocker is used for the treatment of sickle cell anemia and for manufacture of a medicament for the treatment of sickle cell anemia. Moreover, a method for screening for a compound effective in the treatment of sickle cell anemia comprises contacting a candidate compound with the NMDAR and selecting said candidate compound as effective if it is found to selectively reduce activity of the NMDAR.
展开▼